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Several studies have analyzed the association of body mass index (BMI) with either the 
prevalence or incidence of type 2 diabetes (T2D), but no study from Europe or North 
America has yet analyzed and compared the association of BMI with both incident and 
prevalent T2D cases. 
Methods 
Stratified logistic regression was used to calculate odds ratios (OR), and stratified Cox 
proportional hazards regression was used to calculate hazard ratios (HR) of the effect of BMI 
on the prevalence, and incidence of T2D. Wald chi-square statistics were applied when 
comparing the risk estimates. 
Results 
Among prevalent T2D cases, overweight women (BMI 25–29.9 kg/m2) had an OR of 2.83 
(95% confidence interval [CI], 1.92-4.18) and obese women (BMI ≥30 kg/m2) had an OR of 
12.12 (95% CI, 8.32-17.68) when compared with normal weight women (BMI <25 kg/m2). 
Among incident T2D cases, overweight women had a HR of 5.01 (95% CI, 3.59-6.98) and 
obese women had a HR of 15.99 (95% CI, 11.39-22.46) when compared with normal weight 
women. After stratification by level of physical activity, and a justment for age, smoking 
status, and education level, the Wald chi-square statistic for BMI was 180.90 for prevalent 
T2D cases, and 262.03 for incident T2D cases. 
Conclusion 
The predictive effect of BMI was found to be stronger for T2D incidence than T2D 
prevalence. 
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Background 
Type 2 diabetes (T2D) is a chronic disorder of carbohydrate, fat, and protein metabolism. 
Approximately 60 million people in Europe have diabetes [1], and 90% of the diabetes 
patients worldwide have T2D [2]. T2D is largely the result of excess body weight and 
physical inactivity [2]. There is ample evidence that obesity i a major risk factor for T2D, as 
obesity is associated with the rise of insulin resistance in the body, resulting in the 
development of T2D [3-6]. The prevalence of diabetes has been increasi g in Norway [7,8]. 
The Nord-Trøndelag Diabetes Study showed a diabetes prevalence of 0.6% and 2.0% for 
women aged 40–49 and 50–59 years, respectively, in 1984–1986 [7], and the Nord-Trøndelag 
Health Survey (HUNT) showed a prevalence of 0.9% and 2.1%, respectively, in 1995–1997 
[9]. The joint relationship of body mass index (BMI) and physical activity with diabetes 
remains unclear [10-12]. Some research indicates that physical activity is associated with 
T2D independent of obesity [13], but most studies indicate that the relationship between 
physical activity and T2D weakens when BMI is taken into consideration [12,14-16]. 
The Tehran Lipid and Glucose Study (TLGS) included fasting plasma glucose screening and 
2-hour post challenge plasma glucose screening to identify T2D cases in 1999–2001, 2002–
2005, and 2005–2008, and found higher odds ratios (OR) for BMI among incident than 
prevalent T2D cases [17]. However no study from Europe or North America was found 
where the association of BMI with both incident and prevalent T2D cases was analyzed. 
Therefore, using data from the Norwegian Women and Cancer (NOWAC) Study, we 
performed a cross-sectional analysis of data collected in 1998, and a prospective cohort 
analysis of data collected between 1998 and 2005, and compared the OR estimates of BMI in 
relation to T2D prevalence and incidence. 
Methods 
Study population 
The NOWAC Study is a prospective nationwide study which started in 1991 [18], and 
contains data from 170,000 women. Participants were randomly selected from the National 
Population Register of Norway. The external validity of the study has been published 
elsewhere [19]. NOWAC Study participants are assumed to be representative of the female 
Norwegian population in the corresponding age groups. The detailed sample characteristics 
of the NOWAC Study are described elsewhere [19], and updated informati n on the 
NOWAC Study is accessible on the website [18]. 
Out of the 170,000 women enrolled in the NOWAC Study, 33,919 completed the 
questionnaires sent in 1998 and 2005 (age: 47.7 years ±4.3, BMI: 24.4 kg/m2 ± 3.8, 
education level: 12.5 years ±3.2). After exclusion of 2617 participants with missing values, 
the study sample consisted of 31,302. 
Questionnaire and classification 
As T2D typically affects people over 40 years of age [20], in the present analysis prevalent 
T2D cases were defined as participants who reported a diabetes diagnosis in the 1998 
questionnaire, and were 40 years of age or over at the time of diagnosis. If the participants 
gave birth to a child the same year, or the year preceding diabetes diagnosis, it was assumed 
that they had gestational diabetes. Only one woman fulfilled the crit ria for T2D and 
gestational diabetes, and was considered to have gestational diabetes only. 
Incident T2D cases were defined as participants who reported a T2D diagnosis between 1998 
and 2005, and were 40 years of age or over at the time of diagnosis (Table 1). For women 
without a diabetes diagnosis, person-years were calculated from the time of the 1998 
questionnaire until 2005, when the last questionnaire was completed. For incident T2D cases, 
person-years were calculated from the time of the 1998 questionnaire unt l year of diabetes 
diagnosis. 
Table 1 General characteristics of the study sample (n = 33,919) 
 Baseline cohort N = 33,919 Incident T2D cases Prevalent T2D cases 
 N (%)  Mean (SD) N (%)  Mean (SD) N (%)  Mean (SD) 
Age (years)  47.7 (4.3)  48.9 (4.3)  50.3 (3.9) 
40-44 9926 (29.3)  70 (21.4)  25 (12.3)  
45-49 11382 (33.6)  98 (30.0)  43 (21.1)  
50-54 10849 (32.0)  137 (41.9)  107 (52.5)  
55-59 1762 (5.2)  22 (6.7)  29 (14.2)  
BMI*‡§   24.4 (3.8)  29.7 (5.4)  29.8 (6.3) 
Normal weight (<25 kg/m2) 21553 (64.6)  55 (17.6)  47 (23.4)  
Overweight (25–29.9 kg/m2) 9106 (27.3)  126 (40.3)  64 (31.8)  
Obese (≥30 kg/m2) 2709 (8.1)  132 (42.2)  90 (44.8)  
Education level (duration in years)*‡§  12.5 (3.2)  11.7 (3.1)  11.4 (2.9) 
Primary/Intermediate (0–9) 6736 (20.1)  91 (27.9)  63 (31.2)  
Secondary (10-12) 12102 (36.1)  125 (38.3)  83 41.1)  
University (13-16) 10226 (30.5)  88 (27.0)  36 (17.8)  
Postgraduate and above (17+) 4460 (13.3)  22 (6.7)  20 (9.9)  
Physical activity level*‡§  5.6 (1.7)  4.7 (1.8)  4.9 (1.9) 
Low 3686 (11.5)  76 (25.5)  41 (21.4)  
Medium 24229 (75.5)  200 (67.1)  133 (69.3)  
High 4186 (13.0)  22 (7.4)  18 (9.4)  
Smoking status       
Never smoker 13763 (40.6)  124 (37.9)  71 (34.8)  
Former smoker 10582 (31.2)  106 (32.4)  70 (34.3)  
Current smoker 9574 (28.2)  97 (29.7)  63 (30.9)  
Age at diagnosis (years)    53.1 (4.5)  46.3 (4.2) 
40-44   10 (3.1)  75 (36.8)  
45-49   69 (21.1)  70 (34.3)  
50-54   107 (32.7)  59 (28.9)  
55-59   117 (35.8)  0 (0.0)  
60-64   24 (7.3)  0 (0.0)  
*Cohort size was 33,919, but because of missing values, the numbers for some variables do not add up to 33,919. 
‡The total number of incident cases of T2D was 327, but because of missing values, the numbers for some variables do not add 
up to 327. 
§The total number of prevalent cases of T2D was 204, but because of missing values, the numbers for some variables do not 
add up to 204. 
Self-reported information on height and weight was used to calculate BMI (in kg/m2). BMI 
was categorized into three groups: normal weight (BMI <25 kg/m2), overweight (BMI 25–
29.9 kg/m2) and obese (BMI ≥30 kg/m2). Both continuous and categorical BMI variables 
were used in the analyses. 
Smoking status was derived from the replies to two questions in the 1998 questionnaire: 
‘Have you ever smoked?’ (yes, no), and ‘Do you smoke on a daily basis at the moment?’ 
(yes, no). Women who answered ‘no’ to the former were categorized as ‘never smokers’. 
Those who answered ‘yes’ to the former, and ‘no’ to the latter, we categorized as ‘former 
smokers’, and those who answered ‘yes’ to both questions were categorized as ‘current 
smokers’. 
A 10-category scale measured the level of self-reported physical activity in the 1998 
questionnaire, the validity of which has been reported [21]. Responses to questions about 
physical activity were used to assign a category of physical activity: low [1-3], medium [4-7], 
and high [8-10]. Participants also reported education level (duration in years), and age 
(years). 
Statistical analysis 
All analyses were conducted using SPSS version 18. Means (standard deviation, SD) were 
calculated for all continuous variables, and the percentage of partici nts in each category 
was determined for all categorical variables. General chara teristics of the data are presented 
as means with SDs and frequencies, respectively (Table 1). 
To estimate the predictive effect of BMI on the incidence and prevalence of T2D, stratified 
logistic and stratified Cox proportional hazards regression were used. To assess the linear 
trend, the continuous variables (BMI, education level, and physical activity) were used. To 
assess the predictive effect of BMI, the normal weight level was used as a reference in 
stratified logistic regression and stratified Cox proportional hazards regression analyses. A p 
value of <0.05 was considered statistically significant. More than 5% change in beta 
coefficients was used as the cutoff to identify possible confounders, and by this method 
education level, physical activity, and smoking status were identified as confounders of the 
association between BMI and T2D. All independent variables were testd for pairwise 
interaction with BMI with logistic and Cox proportional hazards regression models. A p 
value of <0.05 was considered significant for identifying possible interactions. The 
relationship between BMI and T2D was not found to be linear in our analysis (results not 
shown), and so the categorical variable of BMI was used in the final models instead. In the 
final model, the estimates of the effects of BMI are presented with 95% confidence intervals 
(CI). ORs and hazard ratios (HR) are reported. An OR can be interpret d as a relative risk 
(RR) when the disease prevalence is low [22]. Wald chi-square statistics were reported to 
present the overall predictive effect of BMI on the development of T2D, stratified by physical 
activity for comparison between T2D prevalence and incidence. Both adjusted and 
unadjusted estimates are presented. 
Ethical approval 
The NOWAC Study was approved by the Regional Committee for Medical and Health 
Research Ethics (REK). All women gave written informed consent. 
Results 
T2D prevalence was assessed in 33,919 women, of whom 204 were classified as prevalent 
T2D cases. T2D incidence was assessed in 33,714 women over 7 years of follow-up, and 327 
were classified as incident T2D cases. The characteristics of the study sample, i.e., the 
baseline cohort, and prevalent and incident T2D cases, are shown in Table 1. Compared with 
the baseline cohort, prevalent and incident T2D cases had higher BMI, lower education level, 
and lower level of physical activity. The mean BMI of the baseline cohort was 24.4 kg/m2. A 
higher proportion of incident T2D cases were overweight and obese (combined), compared to 
prevalent T2D cases. The mean BMI of prevalent T2D cases was lightly higher than that of 
incident T2D cases (29.8 vs 29.7 kg/m2). The majority of women in the baseline cohort had a 
normal weight level, while the majority of incident and prevalent T2D cases were obese. 
Compared with prevalent T2D cases, incident T2D cases were on average younger, had a 
slightly lower BMI, a slightly higher education level, and a slightly lower level of physical 
activity (Table 1). 
An interaction between BMI and physical activity was observed in T2D. Figures 1 and 2 
show that the effect of BMI on the incidence and prevalence of T2D changes according to the 
level of physical activity, and the models were therefore stratified by physical activity 
(Figures 1 and 2). Physical activity was identified as the effct modifier, and the three 
categories of physical activity were employed as strata vari bles in the stratified logistic and 
stratified Cox proportional hazards regression analysis. 
Figure 1 Proportion of T2D incidence by BMI and level of physical activity. 
Figure 2 Proportion of T2D prevalence by BMI and level of physical activity. 
The independent effect of BMI on T2D in both unadjusted and multivariate-adjusted models 
is presented in Table 2. Each group had a statistically significantly increased risk of prevalent 
and incident T2D when compared with normal weight women: overweight women had an 
OR of 2.83 (95% CI, 1.92-4.18), and obese women had an OR of 12.12 (95% CI, 8.32-17.68) 
for prevalent T2D. Compared with normal weight women, overweight women had a HR of 
5.01 (95% CI, 3.59-6.98), and obese women had a HR of 15.99 (95% CI, 11.39-22.46) for 
developing incident T2D. After adjustment for age, smoking status, and education level, the 
Wald chi-square statistics for prevalence and incidence were 180.90 and 262.03, respectively, 
showing that BMI has a stronger predictive effect on T2D incidence than prevalence. 
Table 2 Estimates of BMI stratified by level of physical activity for prevalent and 
incident T2D cases 











1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) 
Overweight 3.24 (2.20-4.76) 2.83 (1.92-4.18) 5.09 (3.66-7.07) 5.01 (3.59-6.98) 
Obese 14.20 (9.80-20.59) 12.12 (8.32-17.68) 16.46 (11.79-22.97) 15.99 (11.39-22.46) 
Wald χ2 207.50 180.90 276.64 262.03 
p for trend p < 0.001 P < 0.001 p < 0.001 p < 0.001 
*Adjusted for age, education level and smoking status. 
Discussion 
In this study, we estimated the cross-sectional and prospective relationship between BMI and 
T2D in a nationally-representative sample of middle-aged women in Norway. We observed 
that BMI is a stronger predictor of incident T2D (reported betwe n 1998 and 2005), than 
prevalent T2D (reported in the 1998 questionnaire). Overall, BMI had a stronger predictive 
effect on T2D incidence than T2D prevalence. 
The risk of T2D prevalence was weaker than that for incidence, probably ecause the 
prevalent cases may have reduced their weight by exercise, physical activity, or diet after 
diagnosis. 
Previous validation studies of self-reported height and weight show that participants tend to 
overestimate their height [23], while they tend to underestimate their weight [23-25]. This 
can affect the strength of the association between BMI and T2D, but not the trend. The large 
sample size and a relatively long follow-up time are important strengths of our study. 
Several studies have adjusted for age [14,26-34], smoking status [14,27-31,34], and education 
level [31,35] in their models while using BMI to predict the risk of T2D. We identified the 
same confounders, and included them in our final models. The World Health Organization 
estimates that a BMI of >25 kg/m2 may account for 65%-80% of new diabetes cases [36], 
which is in accordance with our study. Previous research has shown t at physical inactivity 
plays a major role in the etiology of both T2D and obesity. BMI wasnegatively correlated 
with physical activity in our study population (data not shown), in accordance with previous 
studies [34,37,38]. Possible explanations for the role of physical activity as an effect modifier 
in this research may be that physical activity increases sen itivity to insulin [39], and can 
result in weight loss [40]. 
Previous evidence from large cohort studies suggests that the relationship between BMI and 
diabetes may not be linear, and the same was observed in our study. In comparison with 
previous studies, despite differences in the groups of confounders in the model [14,26,31-34], 
study designs [17,31,33], and methodology [32,34], a similar pattern of association between 
BMI and T2D was observed. The results from the NHANES III [26] study showed that 
among women aged less than 55 years, the risk of T2D was relatively less for women with 
BMI 30.0-34.9 kg/m2 than for women with BMI 25.0-29 kg/m2. This is in contrast to our 
study, although we only used one category [BMI ≥30 kg/m2). However, for women aged 55 
years or older, the NHANES III study showed an increased risk of T2D with increasing BMI. 
In general the association between BMI and T2D prevalence in our study i  much higher than 
in other studies [26,31]. 
The HUNT Study [27] from Norway reported estimates of the effect of BMI on T2D 
incidence during 11 years of follow-up. T2D cases were established by clinical history and 
presence or absence of the anti-GAD antibody. T2D incidence was asse sed from 1984–1986 
to 1995–1997, as compared to 1998–2005 in our study. Still, the estimates were very simila , 
showing that despite the use of clinical history and presence or absence of the anti-GAD 
antibody to determine T2D incidence, our study yielded similar risk e timates. Nord-
Trøndelag County, where the HUNT Study was carried out, is considered r presentative of 
the general population of Norway [7], whereas our study population repres nts middle-aged 
women in Norway. Nevertheless, there are some similarities between the results of the 
HUNT study and our study. The mean BMI of prevalent T2D cases in our study was similar 
to the HUNT study during 1995–1997 [9]. The cohort size was similar, as was the proportion 
of participants with BMI ≥30 kg/m2 at baseline. Also the proportion of diabetic participants 
with a BMI of ≥30 kg/m2 in 1995–1997 was similar to that in our study. 
Another study [31] from the US, using self-reported information on diabetes diagnosis, 
weight, and height with telephonic interviews analyzed the OR of BMI for prevalent diabetes. 
No distinction was made between different types of diabetes, or between men and women. 
Compared with normal BMI, the OR for BMI 25–29.9 kg/m2, BMI 30–39.9 kg/m2, and BMI 
.40 kg/m2 were 1.59 (95% CI: 1.46-1.73), 3.44 (95% CI: 3.17-3.74), 7.37 (95% CI: 6.39-
8.50) respectively. The model was adjusted for age, education, smoking, sex, and race or 
ethnicity. Regardless of the use of different cut off points in defining BMI levels, the OR’s 
are considerably lower as compared to our study. 
A study from Finland [32] analyzed the BMI estimates for incident diabetes. The random 
sample of 35–64 year old men and women with no anti-diabetic drug treatment at baseline 
were followed for 10 years. The BMI was calculated using the height and weight 
measurements in a clinical examination. The diabetes diagnosis was established as the 
development of drug-treated diabetes using the information from the nationwide Social 
Insurance Institution drug register, and the FPG/FWBG/PG/WBG levels in the clinical 
examination. The interaction between the independent variables were not considered and sex 
was not included in the final model. The OR’s of BMI 25–30 kg/m2 for diabetes was not 
significant, while the OR’s for BMI >30 kg/m2 was 2.55 (95%CI: 1.10-5.92). The model was 
adjusted for age, waist circumference, use of blood pressure medication, history of high blood 
glucose, physical activity, and consumption of vegetables and fruits. In comparison, the 
results from our study show much stronger association of BMI levels with the prediction of 
type 2 diabetes in the incidence of diabetes. 
Women’s Health Study (WHS) [14] from U.S assessed the predictive effect of BMI on the 
incidence of diabetes during 6.9 (mean) years of follow up. BMI was calculated from self-
reported information on height and weight at the baseline. The type 2 diabetes diagnosis was 
established by annual self-reports by the respondents, and its validity was established. The 
mean BMI was 25.9 kg/m2 in 37878 women. Compared with BMI <25 kg/m2, the OR’s for 
BMI 25- < 30 kg/m2, and BMI ≥30 kg/m2 were 3.22 (95% CI: 2.69-3.87), and 9.06 (95% CI: 
7.60-10.8) respectively. The model was adjusted for age, family history of diabetes, alcohol 
use, smoking status, hormone therapy use, hypertension, high cholesterol, dietary factors, 
randomized Women’s Health Study treatment groups, and physical activity. The relative risks 
of developing type 2 diabetes are in line with our research. 
The Nurses’ Health Study [34] from U.S reported the estimates of BMI on the incidence of 
type 2 diabetes among female nurses aged 30–55 years. The follow up time was 16 years. 
The diagnosis of type 2 diabetes was established by sending follow up questionnaires 
biennially, and its validity was established in a subsample. Compared to BMI <23.0 kg/m2, 
the RR’s of BMI 23.0–24.9 kg/m2, BMI 25.0–29.9 kg/m2, BMI 30.0–34.9 kg/m2, and BMI 
≥35.0 kg/m2 were 2.67 (95% CI: 2.13–3.34), 7.59 (95% CI: 6.27–9.19), 20.1 (95% CI: 16.6–
24.4), and 38.8 (95% CI: 31.9–47.2) respectively. The model was adjusted for age, time, 
family history of diabetes, menopausal status, postmenopausal hormone therapy, dietary 
score, exercise, smoking, and alcohol consumption. The mean BMI was not reported, but the 
relative risks were substantially larger than our study. 
The Framingham Offspring study from the US analyzed BMI estimates to predict the 
incidence of diabetes over 7 years of follow-up [33]. Despite having a hiher mean BMI, and 
a similar follow-up time, the estimates were much weaker compared to our study. In 
comparison with most of the other studies [14,32,33], our study shows a much stronger 
association of BMI with the prediction of incident T2D. Only one study [17] was found 
where the estimates of BMI were reported for both the prevalence a d incidence prediction. 
The TLGS showed higher ORs of BMI for incident diabetes mellitus than prevalent diabetes 
mellitus. Unlike our study, the data collected in the TLGS for the analysis of BMI and 
diabetes was not self-reported. Nonetheless, our study confirms that the same pattern of 
difference between prevalent and incident T2D can successfully be established using self-
reported information. Our results further confirm the widely accepted hypothesis that BMI is 
a strong predictor of incident T2D, and that the relationship with physical activity cannot be 
ignored. 
In conclusion, our study shows that maintaining a normal weight level is beneficial in 
preventing T2D. Our findings show a stronger predictive effect of BMI on T2D incidence 
than T2D prevalence. Overall the findings suggest that the majority of T2D cases can be 
prevented with weight loss. 
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